OTTAWA, Ontario & VANCOUVER, British Columbia--(BUSINESS WIRE)--The University of Ottawa and the Centre for Drug Research and Development (CDRD) today announced that they have signed an affiliation agreement that will allow researchers at the University of Ottawa to access CDRD’s drug development infrastructure and expertise.
“We are pleased to establish this affiliation agreement with CDRD,” said Joe Irvine, Director, Technology Transfer and Business Enterprise (TTBE). “This collaboration provides us with access to specialized facilities and expertise at CDRD which will act as a catalyst for developing University of Ottawa research innovations into new clinical therapies. Strong partnerships promote innovation, and CDRD has established a unique ability in Canada for advancing medical innovation.”
“CDRD is pleased to expand our network of affiliate institutions to the University of Ottawa, and looks forward to working with their talented researchers. By combining their discoveries with CDRD’s full drug development platform, we will be further positioned to achieve our mission of translating academic discoveries into new medicines,” said Natalie Dakers, CEO, CDRD.
Biomedical and life sciences researchers at the University of Ottawa are encouraged to contact TTBE to learn more about potential collaborations with CDRD.
About the University of Ottawa
The University of Ottawa, one of Canada’s top research-intensive universities, is dedicated to preparing the next generation of Canadian researchers and scientists. We are committed to excellence and encourage an interdisciplinary approach to knowledge creation that attracts the best academic talent from across Canada and around the world. The Technology Transfer and Business Enterprise service at the University of Ottawa facilitates the establishment of strategic partnerships that provide new opportunities for collaborative research, technology development and commercialization.
About CDRD
The Centre for Drug Research and Development provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD combines its drug development platform with a commercial arm, which licenses technologies from affiliated institutions and establishes working collaborations with other biotech and life sciences companies. The Government of Canada’s Networks of Centres of Excellence has recognized CDRD as a Centre of Excellence in Commercialization in Research (CECR).